Literature DB >> 13129865

Vitreous surgery for highly myopic eyes with foveal detachment and retinoschisis.

Hideo Kobayashi1, Shoji Kishi.   

Abstract

PURPOSE: To evaluate the efficacy of vitreous surgery for highly myopic eyes with foveal detachment and retinoschisis.
DESIGN: Retrospective comparative interventional case series. PARTICIPANTS: Seven patients (nine highly myopic eyes) with posterior staphyloma with foveal detachment and retinoschisis without macular hole. Preoperative best-corrected visual acuity in nine eyes ranged from 0.02 to 0.4 (average, 0.17).
METHODS: Vitreous surgery performed on all nine eyes consisted of core vitrectomy, surgically induced posterior vitreous detachment (three eyes), removal of the premacular vitreous cortex and internal limiting membrane in the posterior staphyloma, and 30% SF(6) gas tamponade. Patients were instructed to maintain a prone position for at least 1 day after surgery. The postoperative follow-up period ranged from 6 to 42.5 months (average, 20.4 months). MAIN OUTCOME MEASURES: Visual acuity, retinal tomography monitored by optical coherence tomography.
RESULTS: In eight of the nine eyes, foveal detachment and retinoschisis gradually decreased in height, and these eyes finally attained foveal attachment and visual improvement within 6 months postoperatively. The postoperative best-corrected visual acuity of these eight eyes ranged from 0.4 to 0.6 (average, 0.48). One eye developed a full-thickness macular hole during vitreous surgery, and its postoperative best-corrected visual acuity was 0.08.
CONCLUSIONS: Foveal detachment and retinoschisis in highly myopic eyes resolved after vitrectomy. Vitreous surgery might have a rationale as prophylactic treatment for highly myopic eyes at high risk of macular hole development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129865     DOI: 10.1016/S0161-6420(03)00714-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  37 in total

1.  Vitrectomy and internal limiting membrane peeling without gas tamponade for myopic foveoschisis.

Authors:  Su Jin Lim; Yoon Hyung Kwon; Soon Hyun Kim; Yong Sung You; Oh Woong Kwon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-14       Impact factor: 3.117

2.  Vitrectomy and gas tamponade without internal limiting membrane peeling for myopic foveoschisis.

Authors:  A K H Kwok; T Y Y Lai; W W K Yip
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  Perifoveal vitreous detachment and its macular complications.

Authors:  Mark W Johnson
Journal:  Trans Am Ophthalmol Soc       Date:  2005

4.  Myopic traction maculopathy: study with spectral domain optical coherence tomography and review of the literature.

Authors:  V Konidaris; S Androudi; P Brazitikos
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

Review 5.  Vitreous anatomy and the vitreomacular correlation.

Authors:  Shoji Kishi
Journal:  Jpn J Ophthalmol       Date:  2016-05-10       Impact factor: 2.447

Review 6.  Myopic foveoschisis: a clinical review.

Authors:  R Gohil; S Sivaprasad; L T Han; R Mathew; G Kiousis; Y Yang
Journal:  Eye (Lond)       Date:  2015-03-06       Impact factor: 3.775

7.  Gas tamponade for myopic foveoschisis with foveal detachment.

Authors:  Ting-Yu Wu; Chang-Hao Yang; Chung-May Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-10       Impact factor: 3.117

8.  Diagnosis and treatment of myopic traction maculopathy.

Authors:  Ping-Bo Ouyang; Xuan-Chu Duan; Xiao-Hua Zhu
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

9.  Pathology of macular foveoschisis associated with degenerative myopia.

Authors:  Johnny Tang; Michael B Rivers; Andrew A Moshfeghi; Harry W Flynn; Chi-Chao Chan
Journal:  J Ophthalmol       Date:  2010-08-12       Impact factor: 1.909

10.  Late recurrence of myopic foveoschisis after successful repair with primary vitrectomy and incomplete membrane peeling.

Authors:  Gonzalo Sepúlveda; Stanley Chang; K Bailey Freund; SungPyo Park; Quan V Hoang
Journal:  Retina       Date:  2014-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.